Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

ClinicalTrials.gov ID: NCT00326105

Public ClinicalTrials.gov record NCT00326105. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo- Controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SRTM) in Combination With an Antidepressant in the Treatment of Patients With Major Depressive Disorder With Inadequate Response to an Antidepressant Treatment (PEARL STUDY)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of quetiapine SR in combination with an antidepressant versus an antidepressant alone in patients with MDD with inadequate response to an antidepressant treatment. PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Study identification

NCT ID
NCT00326105
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
450 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2006 (Type not available)
Primary completion
Not listed
Completion
Jul 2007 (Actual)
Last update posted
Mar 25, 2009

2006 – 2007

United States locations

U.S. sites
56
U.S. states
25
U.S. cities
56
Facility City State ZIP Site status
Research Site Phoenix Arizona — —
Research Site El Centro California — —
Research Site Irvine California — —
Research Site Oceanside California — —
Research Site San Diego California — —
Research Site Pueblo Colorado — —
Research Site Coral Springs Florida — —
Research Site DeLand Florida — —
Research Site Gainsville Florida — —
Research Site Hialeah Florida — —
Research Site Jacksonville Florida — —
Research Site Miami Florida — —
Research Site Orlando Florida — —
Research Site West Palm Beach Florida — —
Research Site Atlanta Georgia — —
Research Site Roswell Georgia — —
Research Site Hoffman Estates Illinois — —
Research Site Naperville Illinois — —
Research Site Oak Brook Illinois — —
Research Site Indianapolis Indiana — —
Research Site Lafayette Indiana — —
Research Site Valparaiso Indiana — —
Research Site Prairie Village Kansas — —
Research Site Wichita Kansas — —
Research Site Shreveport Louisiana — —
Research SIte Glen Burnie Maryland — —
Research Site Braintree Massachusetts — —
Research Site Springfield Massachusetts — —
Research Site Clinton Township Michigan — —
Research Site Kalamazoo Michigan — —
Research Site Royal Oak Michigan — —
Research Site Saint Charles Missouri — —
Research Site St Louis Missouri — —
Research Site Cherry Hill New Jersey — —
Research Site Clementon New Jersey — —
Research Site Cedarhurst New York — —
Research Site New York New York — —
Research Site Olean New York — —
Research Site Rochester New York — —
Research Site Staten Island New York — —
Research Site Beechwood Ohio — —
Research Site Toledo Ohio — —
Research Site Norman Oklahoma — —
Research Site Oklahoma City Oklahoma — —
Research Site Philadelphia Pennsylvania — —
Research Site Lincoln Rhode Island — —
Research Site Columbia South Carolina — —
Research Site Memphis Tennessee — —
Research Site Friendswood Texas — —
Research Site Houston Texas — —
Research Site San Antonio Texas — —
Research SIte Wichita Falls Texas — —
Research Site Salt Lake City Utah — —
Research Site Arlington Virginia — —
Research Site Richmond Virginia — —
Research Site Bellevue Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00326105, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 25, 2009 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00326105 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →